Literature DB >> 33017789

N-substitution in isatin thiosemicarbazones decides nuclearity of Cu(II) complexes - Spectroscopic, molecular docking and cytotoxic studies.

Jebiti Haribabu1, Othman I Alajrawy2, Kumaramangalam Jeyalakshmi3, Chandrasekar Balachandran4, Dhanabalan Anantha Krishnan5, Nattamai Bhuvanesh6, Shin Aoki7, Karuppannan Natarajan8, Ramasamy Karvembu9.   

Abstract

The mono- (1) and bi-nuclear (2) copper(II) complexes containing N-substituted isatin thiosemicarbazone(s) were synthesized, and characterized by analytical and spectroscopic (UV-Visible, FT-IR and EPR) techniques. Bimetallic nature of complex 2 was confirmed by single crystal X-ray crystallography. The structures predicted by spectroscopic and crystallographic methods were validated by computational studies. From the spectroscopic, crystallographic and computational data, the structures were found to be distorted square planar for 1 and distorted square pyramidal for 2. Molecular docking studies showed hydrogen bonding and hydrophobic interactions of the complexes with tyrosinase kinase receptors. Complex 1 exhibited promising cytotoxic activity against Jurkat (leukemia) cell line, and complex 2 displayed more activity against HeLa S3 (cervical) and Jurkat cell lines with the IC50 values of 3.53 and 3.70 μM, respectively. Cytotoxicity of 1 (Jurkat) and 2 (Jurkat and HeLa S3) was better than that of cisplatin. Morphological changes in A549 (lung), HeLa S3 and Jurkat cell lines were examined in presence of the active complexes with the co-staining of Hoechst, AO (acridine orange) and EB (ethidium bromide) by fluorescence microscope.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cu(II) complexes; Cytotoxicity; Molecular docking; Spectroscopy; Theoretical calculations; Thiosemicarbazones

Mesh:

Substances:

Year:  2020        PMID: 33017789     DOI: 10.1016/j.saa.2020.118963

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  5 in total

1.  Effective inhibition of insulin amyloid fibril aggregation by nickel(II) complexes containing heterocyclic thiosemicarbazones.

Authors:  Kannayiram Gomathi; Jebiti Haribabu; Sivaraj Saranya; Dasararaju Gayathri; Kumaramangalam Jeyalakshmi; Subramanian Sendilvelan; Cesar Echeverria; Ramasamy Karvembu
Journal:  Eur Biophys J       Date:  2021-08-29       Impact factor: 1.733

Review 2.  A Mini Review on Isatin, an Anticancer Scaffold with Potential Activities against Neglected Tropical Diseases (NTDs).

Authors:  Shefali Chowdhary; Amandeep Arora; Vipan Kumar
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-27

3.  New Derivatives of 5-((1-Methyl-Pyrrol-2-yl) Methyl)-4-(Naphthalen-1-yl)-1,2,4-Triazoline-3-Thione and Its Coordination Compounds with Anticancer Activity.

Authors:  Agnieszka Czylkowska; Suneel Lanka; Małgorzata Szczesio; Kamila Czarnecka; Paweł Szymański; Monika Pitucha; Aneta Drabińska; Bruno Cury Camargo; Jacek Szczytko
Journal:  Int J Mol Sci       Date:  2022-08-15       Impact factor: 6.208

Review 4.  Advances in thiosemicarbazone metal complexes as anti-lung cancer agents.

Authors:  Xian-Guang Bai; Yunyun Zheng; Jinxu Qi
Journal:  Front Pharmacol       Date:  2022-09-27       Impact factor: 5.988

5.  Design and synthesis of heterocyclic azole based bioactive compounds: Molecular structures, quantum simulation, and mechanistic studies through docking as multi-target inhibitors of SARS-CoV-2 and cytotoxicity.

Authors:  Jebiti Haribabu; Vasavi Garisetti; Rahime Eshaghi Malekshah; Swaminathan Srividya; Dasararaju Gayathri; Nattamai Bhuvanesh; Ramalinga Viswanathan Mangalaraja; Cesar Echeverria; Ramasamy Karvembu
Journal:  J Mol Struct       Date:  2021-10-21       Impact factor: 3.196

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.